Wijnker Dennis 4
4 · LifeMD, Inc. · Filed Aug 20, 2024
Insider Transaction Report
Form 4
LifeMD, Inc.LFMD
Wijnker Dennis
Chief Technology Officer
Transactions
- Award
Common Stock
2022-04-04+20,000→ 20,000 total - Award
Common Stock
2024-08-18+80,000→ 100,000 total - Disposition to Issuer
Stock Option (Right to Buy)
2024-08-18−80,000→ 0 totalExercise: $3.78→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]The restricted shares vest in full on April 4, 2025.
- [F2]The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021.